📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Crinetics

1.1 - Company Overview

Crinetics Logo

Crinetics

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of clinical-stage pharmaceutical research and development focused on therapies for people with rare endocrine diseases.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Crinetics

Viking Therapeutics Logo

Viking Therapeutics

HQ: United States Website
  • Description: Provider of novel therapeutics in development targeting metabolic and endocrine disorders, including oral TRβ agonists (VK2809 for lipid/metabolic disorders incl. NASH; VK0214 for X-ALD), a dual GLP-1/GIP agonist (VK2735) for obesity, an oral FBPase inhibitor (VK0612) for type 2 diabetes, a DGAT-1 inhibitor (VK1430) for hypertriglyceridemia/NASH, and an oral non-steroidal SARM (VK5211) for recovery after non-elective hip fracture surgery.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Viking Therapeutics company profile →
HepaRegeniX Logo

HepaRegeniX

HQ: Germany Website
  • Description: Provider of drug candidates targeting MKK4 to restore hepatocyte regeneration for acute and chronic liver diseases. Pipeline includes HRX-0215, a first-in-class MKK4 inhibitor in clinical trials, and HRX-0233, a second MKK4 inhibitor under preclinical collaborations for cancer combination therapy.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full HepaRegeniX company profile →
Verlyx Logo

Verlyx

HQ: Canada Website
  • Description: Provider of liver-targeting therapeutic agents for the treatment of liver diseases, including lead product VLX103, a proprietary form of pentamidine combining hepatoselective and hepatoprotective properties. Privately held pharmaceutical company.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Verlyx company profile →
NGM Bio Logo

NGM Bio

HQ: United States Website
  • Description: Provider of biotherapeutic drug discovery focused on the gastrointestinal endocrine system, developing: NGM707 (ILT2/ILT4 antagonist), NGM831 (ILT3 antagonist), NGM438 (LAIR1 antagonist) for advanced solid tumors; NGM120 (GFRAL antagonist) for advanced solid tumors and cachexia; NGM621 (anti-Complement C3) for geographic atrophy; aldafermin (FGF19 analog) for NASH F4 and primary sclerosing cholangitis.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full NGM Bio company profile →
Omthera Logo

Omthera

HQ: United States Website
  • Description: Provider of specialty pharmaceutical therapies in clinical development for dyslipidemia and elevated triglyceride levels, serving patients at increased risk of cardiovascular disease.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Omthera company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Crinetics

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Crinetics

2.2 - Growth funds investing in similar companies to Crinetics

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Crinetics

4.2 - Public trading comparable groups for Crinetics

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Crinetics

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Crinetics

What does Crinetics do?

Crinetics is a provider of clinical-stage pharmaceutical research and development focused on therapies for people with rare endocrine diseases.

Who are Crinetics's competitors?

Crinetics's competitors and similar companies include Viking Therapeutics, HepaRegeniX, Verlyx, NGM Bio, and Omthera.

Where is Crinetics headquartered?

Crinetics is headquartered in United States.

How many employees does Crinetics have?

Crinetics has 1,000 employees 🔒.

When was Crinetics founded?

Crinetics was founded in 2010 🔒.

What sector and industry vertical is Crinetics in?

Crinetics is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Crinetics

Who are the top strategic acquirers in Crinetics's sector and industry

Top strategic M&A buyers and acquirers in Crinetics's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Crinetics?

Top strategic M&A buyers groups and sectors for Crinetics include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Crinetics's sector and industry vertical

Which are the top PE firms investing in Crinetics's sector and industry vertical?

Top PE firms investing in Crinetics's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Crinetics's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Crinetics's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Crinetics's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Crinetics include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Crinetics's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Crinetics?

The key public trading comparables and valuation benchmarks for Crinetics include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Crinetics for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Crinetics with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Crinetics's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Crinetics with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Crinetics's' sector and industry vertical?

Access recent funding rounds and capital raises in Crinetics's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Crinetics